United Therapeutics Corp (STU:UTH)
€ 251 -5 (-1.95%) Market Cap: 11.20 Bil Enterprise Value: 9.25 Bil PE Ratio: 12.90 PB Ratio: 2.26 GF Score: 87/100

United Therapeutics Corp at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript

Sep 23, 2020 / 03:40PM GMT
Release Date Price: €86.5 (-0.57%)
Hartaj Singh
Oppenheimer & Co. Inc., Research Division - Research Analyst

Thank you, David, for introducing us. And we were already having a pretty good conversation with Martine and I. We are really happy to again have Martine Rothblatt, Dr. Rothblatt, with us today on our OpCo Health Care Conference to provide us an update with United Therapeutics. We also have Dewey Steadman here, who will give us a quick intro, and then we can get the conversation started.

Dewey Steadman
United Therapeutics Corporation - Head of IR

Yes. Good morning. Our remarks today may include forward-looking information about our business, and please see our SEC filings for risks and uncertainties that could cause actual results to differ. And thank you. So I'll turn it back over to you, Hartaj.

Hartaj Singh
Oppenheimer & Co. Inc., Research Division - Research Analyst

Thank you, Dewey. And you are very lucky, I didn't take my morning pot cookie with that background. I'm just kidding, I'm just kidding. That would definitely throw

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot